Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 12, 2007. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on March 9, 2007. Each individual acquired 9 shares through the personal contribution element and 9 shares through the company matching element of the ShareReward Plan. The purchase price was GBP 14.35 per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of director shareholdings under Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: March 9, 2007.
- Share Price: GBP 14.35 per Ordinary Share.
- Participants: Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty.
- Acquisition Volume: 18 shares per individual (9 personal, 9 company match).
- Plan Details: Transactions occurred under the ShareReward Plan entered into on October 5, 2001.